首页> 外国专利> Rapid, massively parallel single-cell drug response measurements via live cell interferometry

Rapid, massively parallel single-cell drug response measurements via live cell interferometry

机译:通过活细胞干涉法快速,大规模并行进行单细胞药物反应测量

摘要

#$%^&*AU2018232924B220200716.pdf#####RAPID, MASSIVELY PARALLEL SINGLE-CELL DRUG RESPONSE MEASUREMENTS VIA LIVE CELL INTERFEROMETRY ABSTRACT A central question in cancer therapy is how individual cells within a population of tumor cells respond to drugs designed to arrest their growth. However, the absolute growth of cells, their change in physical mass, whether cancerous or physiologic, is difficult to measure directly with traditional techniques. Embodiments of the invention provide live cell interferometry (LCI) for rapid, realtime quantification of cell mass in cells exposed to a changing environment. Overall, LCI provides a conceptual advance for assessing cell populations to identify, monitor, and measure single cell responses, such as to therapeutic drugs.
机译:#$%^&* AU2018232924B220200716.pdf #####快速,并行的单细胞药物反应通过活细胞干涉法进行测量抽象癌症治疗中的一个核心问题是肿瘤细胞群中的单个细胞如何对旨在阻止其生长的药物做出反应。但是,细胞的绝对生长不论是癌变还是生理变迁,都很难直接测量身体质量的变化传统技术。本发明的实施例提供了活细胞干涉测量法(LCI),用于快速,实时量化暴露于变化环境中的细胞的细胞质量。总体,LCI为评估细胞群以鉴定,监测和鉴定细胞提供了概念上的进展。测量单细胞反应,例如对治疗药物的反应。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号